Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 181

1.

Cell therapy for basement membrane-linked diseases.

Nyström A, Bornert O, Kühl T.

Matrix Biol. 2016 Sep 5. pii: S0945-053X(16)30068-3. doi: 10.1016/j.matbio.2016.07.012. [Epub ahead of print] Review.

PMID:
27609402
2.

Claudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic Studies.

Randall K, Henderson N, Reens J, Eckersley S, Nyström AC, South MC, Balendran CA, Böttcher G, Hughes G, Price SA.

PLoS One. 2016 Sep 6;11(9):e0162076. doi: 10.1371/journal.pone.0162076. eCollection 2016.

3.

RNA-based therapies for genodermatoses.

Bornert O, Peking P, Bremer J, Koller U, van den Akker PC, Aartsma-Rus A, Pasmooij AM, Murauer EM, Nyström A.

Exp Dermatol. 2016 Jul 4. doi: 10.1111/exd.13141. [Epub ahead of print] Review.

PMID:
27376675
4.

Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy.

Bornert O, Kühl T, Bremer J, van den Akker PC, Pasmooij AM, Nyström A.

Mol Ther. 2016 Aug;24(7):1302-11. doi: 10.1038/mt.2016.92. Epub 2016 May 9.

PMID:
27157667
5.

Generation of a Functional Non-Shedding Collagen XVII Mouse Model: Relevance of Collagen XVII Shedding in Wound Healing.

Jacków J, Schlosser A, Sormunen R, Nyström A, Sitaru C, Tasanen K, Bruckner-Tuderman L, Franzke CW.

J Invest Dermatol. 2016 Feb;136(2):516-25. doi: 10.1016/j.jid.2015.10.060. Epub 2015 Nov 18.

PMID:
26967482
6.

NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?

Friberg S, Nyström AM.

J Nanobiotechnology. 2016 Mar 9;14:17. doi: 10.1186/s12951-016-0172-2.

7.

A Gene Gun-mediated Nonviral RNA trans-splicing Strategy for Col7a1 Repair.

Peking P, Koller U, Hainzl S, Kitzmueller S, Kocher T, Mayr E, Nyström A, Lener T, Reichelt J, Bauer JW, Murauer EM.

Mol Ther Nucleic Acids. 2016 Mar 1;5:e287. doi: 10.1038/mtna.2016.3.

PMID:
26928235
8.

Collagen VII Half-Life at the Dermal-Epidermal Junction Zone: Implications for Mechanisms and Therapy of Genodermatoses.

Kühl T, Mezger M, Hausser I, Guey LT, Handgretinger R, Bruckner-Tuderman L, Nyström A.

J Invest Dermatol. 2016 Jun;136(6):1116-23. doi: 10.1016/j.jid.2016.02.002. Epub 2016 Feb 18.

PMID:
26899947
9.

Collagen XVII Shedding Suppresses Re-Epithelialization by Directing Keratinocyte Migration and Dampening mTOR Signaling.

Jacków J, Löffek S, Nyström A, Bruckner-Tuderman L, Franzke CW.

J Invest Dermatol. 2016 May;136(5):1031-41. doi: 10.1016/j.jid.2016.01.012. Epub 2016 Jan 28.

PMID:
26827763
10.

One-pot Synthesis of Metal-Organic Frameworks with Encapsulated Target Molecules and Their Applications for Controlled Drug Delivery.

Zheng H, Zhang Y, Liu L, Wan W, Guo P, Nyström AM, Zou X.

J Am Chem Soc. 2016 Jan 27;138(3):962-8. doi: 10.1021/jacs.5b11720. Epub 2016 Jan 12.

PMID:
26710234
11.

Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression.

Mittapalli VR, Madl J, Löffek S, Kiritsi D, Kern JS, Römer W, Nyström A, Bruckner-Tuderman L.

Cancer Res. 2016 Feb 15;76(4):940-51. doi: 10.1158/0008-5472.CAN-15-1348. Epub 2015 Dec 16.

PMID:
26676755
12.

Cancer Metastases: Early Dissemination and Late Recurrences.

Friberg S, Nyström A.

Cancer Growth Metastasis. 2015 Nov 29;8:43-9. doi: 10.4137/CGM.S31244. eCollection 2015. Review.

13.

Epidermal Basement Membrane in Health and Disease.

Has C, Nyström A.

Curr Top Membr. 2015;76:117-70. doi: 10.1016/bs.ctm.2015.05.003. Epub 2015 Jun 19. Review.

PMID:
26610913
14.

Nanoparticle dosage-a nontrivial task of utmost importance for quantitative nanosafety research.

Feliu N, Pelaz B, Zhang Q, Del Pino P, Nyström A, Parak WJ.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 May;8(3):479-92. doi: 10.1002/wnan.1378. Epub 2015 Nov 21. Review.

PMID:
26589577
15.

Histamine-functionalized copolymer micelles as a drug delivery system in 2D and 3D models of breast cancer.

Zhang Y, Lundberg P, Diether M, Porsch C, Janson C, Lynd NA, Ducani C, Malkoch M, Malmström E, Hawker CJ, Nyström AM.

J Mater Chem B Mater Biol Med. 2015 Mar 28;3(12):2472-2486.

16.

Disulfide-Functionalized Unimolecular Micelles as Selective Redox-Responsive Nanocarriers.

Porsch C, Zhang Y, Montañez MI, Malho JM, Kostiainen MA, Nyström AM, Malmström E.

Biomacromolecules. 2015 Sep 14;16(9):2872-83. doi: 10.1021/acs.biomac.5b00809. Epub 2015 Aug 11.

PMID:
26200248
17.

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms.

Nyström A, Thriene K, Mittapalli V, Kern JS, Kiritsi D, Dengjel J, Bruckner-Tuderman L.

EMBO Mol Med. 2015 Jul 20;7(9):1211-28. doi: 10.15252/emmm.201505061.

18.

Nanotechnology in the war against cancer: new arms against an old enemy - a clinical view.

Friberg S, Nyström AM.

Future Oncol. 2015;11(13):1961-75. doi: 10.2217/fon.15.91.

19.

High Local Concentrations of Intradermal MSCs Restore Skin Integrity and Facilitate Wound Healing in Dystrophic Epidermolysis Bullosa.

Kühl T, Mezger M, Hausser I, Handgretinger R, Bruckner-Tuderman L, Nyström A.

Mol Ther. 2015 Aug;23(8):1368-79. doi: 10.1038/mt.2015.58. Epub 2015 Apr 10.

20.

Matrix effect explained by unexpected formation of peptide in acidified plasma.

Ahnoff M, Nyström AC, Schweikart F, Ekdahl A.

Bioanalysis. 2015;7(3):295-306. doi: 10.4155/bio.14.271.

PMID:
25697188
Items per page

Supplemental Content

Loading ...
Write to the Help Desk